Most healthcare PR firm decks look identical. Logos of household-name health systems. A handful of Becker's placements. A line about “FDA expertise” that means somebody on the team Googled the word. By the third RFP response, the marketing director can no longer tell two firms apart — and that is exactly when the wrong firm gets hired.

This is the operator's checklist. If you are running an RFP for a hospital system, a 510(k) device launch, a PMA-class submission, or a service-line introduction, this is the 30-point evaluation, the 8-to-14-month selection timeline, and the budget benchmarks that will keep you from picking the firm with the slickest deck instead of the firm that can actually deliver coverage in Modern Healthcare, MedTech Dive, MedPage Today, and the trade outlets your buyers actually read. For the long-form decision framework, our companion piece on how to choose a healthcare PR firm covers the eight evaluation criteria in depth — start there, then come back here for the action checklist.

TL;DR

  • Start the RFP 8–14 months before launch day. Selection takes 8–12 weeks; the firm needs 6–12 months of pre-launch runway after that.
  • Use a 30-point checklist across regulatory, media, MLR, KOL, crisis, team, measurement, and conflicts. Score each finalist 0–3.
  • Hospital vs. device PR are different specialties. Verify category-specific journalist relationships and named-team tenure before signing.
  • Budget realistically: $40K–$400K+ for the launch arc, $8K–$25K/month for the program afterward, plus $5K–$15K/month for crisis-readiness if you have a recall risk profile.
  • The deck is not the firm. Reference checks with three former clients (one churned) reveal more than any pitch.

The 8-to-14-Month Selection Timeline

Healthcare PR firm selection runs on two clocks: the RFP clock (how long it takes to pick a firm) and the launch clock (how long the firm needs to do the work that produces results). Compressing either is the single most expensive mistake we see in healthcare marketing.

Months 14–12 before launch — Build the long list. Work from category fit, not generic prestige. For a 510(k) cardiology device, the long list is the 8 to 12 firms with documented coverage in Cardiovascular Business, HRX, tctMD, MedTech Dive's cardio beat, and the relevant peer-reviewed journals — not the firms with the most billboards. For a hospital system rebrand, the long list is firms with documented community-relations, donor-relations, and U.S. News positioning work in similarly-sized markets. Get to a long list of 8–12 firms.

Months 12–10 — RFP and capability calls. Issue the RFP, take 60-minute capability calls with each respondent, and cut to a finalist list of 3–4 firms. Capability calls reveal more than written responses; insist on the senior team being on the call, not just the new-business lead.

Months 10–9 — Finalist presentations and references. Have each finalist present a draft 90-day plan against your specific launch milestones. Run reference calls — three references each, including at least one churned client. Negotiate the SOW, the named-team continuity guarantee, and the conflict policy. Sign.

Months 9–0 — Pre-launch execution. The firm now has the runway to do what it should: media training, MLR-approved press materials, journalist relationship building, KOL roster development, conference activation planning, and the crisis playbook. For a PMA device or a major hospital brand launch, push every milestone three months earlier.

The 30-Point Evaluation Checklist

Score each finalist 0–3 on each line. Anything below a 2 on a critical category (regulatory, MLR, crisis, or conflicts) is a near-disqualifier regardless of total score.

Regulatory Fluency (5 items)

  • Names FDA promotional rules, OPDP guidance, and FTC truth-in-advertising without prompting
  • Walks through a recent FDA-related decision they made on a client account, with specifics
  • Distinguishes 510(k), De Novo, and PMA promotional postures
  • Demonstrates HIPAA-aware patient story workflow
  • Has a written claims-substantiation process tied to clinical evidence

Trade & Clinical Media Depth (5 items)

  • Names the 8–15 reporters who cover your category, with current beats
  • Shows three earned placements in your category in the last 12 months — bylines, not metrics
  • Has documented relationships with relevant peer-reviewed journal press offices
  • Lists category society contacts (AdvaMed, AHA, AMA, AAOS, ACS, HIMSS, RSNA, AAGL, ACC)
  • Demonstrates conference-PR pattern at the events your customers actually attend

MLR Integration (4 items)

  • Names a specific MLR tool stack (Veeva PromoMats, IQVIA Benchmark, or your internal review)
  • Walks through their version-control discipline for MLR-bound copy
  • Reports a current rework rate below 15% on PR-drafted copy
  • Builds claims-mapped reference libraries before drafting

KOL & HCP Capability (3 items)

  • Has documented KOL identification, vetting, and Sunshine Act-compliant contracting
  • Distinguishes HCP-facing PR from DTC and consumer-press PR
  • Demonstrates podium and trade-floor PR pattern at relevant conferences

Crisis Communications (3 items)

  • Has a written crisis playbook with named decision-makers and escalation matrices
  • Walks through hold-statement templates and pre-positioned journalist contacts
  • Has a documented post-mortem process from a real client crisis

Team Continuity (3 items)

  • Names senior team members with healthcare tenure documented in writing
  • Will commit to named-team continuity in the SOW, not just the pitch
  • Identifies a partner-level escalation contact for when something goes wrong

Measurement Framework (4 items)

  • Leads with share of voice and message pull-through, not AVE or impressions
  • Uses tier-weighted earned-media value, not flat impression counts
  • Tracks journalist relationship depth (warm reporter count, response rates)
  • Aligns measurement to business indicators (qualified inbound, surgeon adoption signal, payer meetings)

Conflict-of-Interest Policy (3 items)

  • Provides a written competitor-conflict policy
  • Discloses current healthcare client roster for category-overlap review
  • Will accept a competitor-blocking clause in the contract

Use the Checklist on Your Live RFP

45-min call. Bring your RFP shortlist and your launch milestones. We score each finalist on the 30-point checklist, flag the gaps that matter, and tell you which firm fits your stage. No pitch.

Book the RFP Scoring Call →

Hospital System vs. Medical Device: Side-by-Side

The headline difference is audience. Hospital system PR carries an extra layer of community, donor, payer, and accreditation work that device PR does not. Device PR carries a regulatory and clinical-evidence overlay hospital PR does not. The criteria above apply to both, but the weighting shifts.

For a hospital system, over-index on local broadcast and print relationships, accreditation storytelling depth (Magnet, Leapfrog, U.S. News, DNV-GL), donor and foundation communications, payer-coalition positioning, and crisis preparedness for never-events, cyber incidents (CommonSpirit, Change Healthcare, and Ascension all in recent years), and physician-misconduct stories. The firm should also know the specific reporters at your local market's daily paper, business journal, and broadcast affiliates — those reporters cover your community even when the trade press does not.

For a medical device launch, over-index on trade and clinical journalist relationships, KOL roster depth, peer-reviewed publication strategy aligned with journal lead times, conference-PR pattern at HIMSS, AAOS, RSNA, AdvaMed, and your category-specific events, FDA promotional compliance discipline, and crisis preparedness for recalls, MAUDE adverse-event escalations, 483 observations, and warning letters. Companion read: medical device media relations and medical device press release strategy.

For a system that includes both — a hospital running a service-line launch around a new device platform, or a device company with a marquee health-system implementation — the firm needs both benches. Verify named partners on each side, not one person trying to cover both.

Budget Benchmarks for 2026

Pricing in healthcare PR remains opaque. Three patterns hold across the firms we have benchmarked.

Launch project budgets. A 510(k) medical device launch typically runs $40,000 to $150,000 across a 6- to 9-month arc. PMA-class launches, drug-device combinations, and major hospital brand launches sit at $150,000 to $400,000+ over 9 to 18 months. National launches with broadcast, KOL programs, multi-conference activation, and crisis-readiness scope frequently exceed $250,000.

Ongoing program retainers. Most healthcare PR retainers run $8,000 to $25,000 per month. Below $8,000, you typically get junior staff and reactive press release distribution. Hospital systems commonly sit in the $10,000 to $30,000 monthly range; mid-stage device companies $12,000 to $35,000; pre-IPO and public device companies $25,000+ with investor relations factored in.

Crisis-readiness retainers. Add $5,000 to $15,000 monthly for any company with a meaningful recall risk profile or a public-investor base. The cost of not having this in place — measured in market-cap loss or community trust erosion — vastly exceeds the retainer math.

For broader agency-cost patterns, see healthcare marketing agency pricing and medical device marketing agency cost.

The Reference-Check Script

Reference calls are where the deck stops mattering. Ask each reference these six questions and listen for the unscripted detail:

  1. What did the firm do that exceeded your expectations, with a specific example? Generic praise is a tell.
  2. What did the firm do that disappointed you? Every honest reference has a real answer.
  3. Was the team you signed with the team that ran the account in year two? Bait-and-switch shows up here.
  4. How did they handle a crisis or unexpected news cycle? Specific details matter; vague reassurance does not.
  5. What is their MLR rework rate on the copy you receive? Above 30% means the firm does not actually understand your regulatory regime.
  6. Would you rehire them today, knowing what you know now? The hesitation, not the answer, tells you the truth.

Always ask for a churned-client reference. Firms that refuse are protecting something. Firms that supply one are confident.

What Year-One Success Actually Looks Like

A successful healthcare PR engagement at the 12-month mark looks like this. The firm has earned bylined coverage in 8 to 15 trade and clinical outlets relevant to your audience, with named journalists who now take your CMO's call. Message pull-through across that coverage is 60%+ — your priority messages appear in stories rather than getting edited out. Conference activations have produced documented podium and trade-floor outcomes with measurable post-event business indicators. A written crisis playbook exists, has been tabletop-tested, and the team knows their roles. MLR rework rates on PR-drafted copy are below 15%. The C-suite has been media-trained and successfully delivered earned interviews. Investor and analyst sentiment, where relevant, has measurably improved.

That outcome does not come from picking the firm with the best deck. It comes from running the 30-point checklist with discipline, scoring on evidence rather than vibe, kicking off 8 to 14 months before launch day, and writing named-team continuity into the contract. For broader launch context, see our medical device product launch guide and marketing automation workflows for a medical device launch.